|
RTKN2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.339800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.768400E-01 |
| Normal-vs-Stage2 |
4.920400E-01 |
| Normal-vs-Stage3 |
6.293000E-01 |
| Normal-vs-Stage4 |
3.028200E-02 |
| Stage1-vs-Stage2 |
4.165200E-01 |
| Stage1-vs-Stage3 |
5.422000E-01 |
| Stage1-vs-Stage4 |
9.300100E-03 |
| Stage2-vs-Stage3 |
1.971050E-01 |
| Stage2-vs-Stage4 |
5.236600E-03 |
| Stage3-vs-Stage4 |
3.179500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.020800E-01 |
| Normal-vs-AfricanAmerican |
4.524400E-01 |
| Normal-vs-Asian |
4.285600E-01 |
| Caucasian-vs-AfricanAmerican |
5.188800E-01 |
| Caucasian-vs-Asian |
4.372200E-01 |
| AfricanAmerican-vs-Asian |
7.665800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.615400E-01 |
| Normal-vs-Female |
8.346800E-01 |
| Male-vs-Female |
5.814200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.524380E-01 |
| Normal-vs-Age(41-60Yrs) |
4.233600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.747400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.395400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.271000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.238240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.837400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.492800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.44199999996264E-06 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.0057999999934E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.101800E-01 |
| Normal-vs-Grade 2 |
8.725400E-01 |
| Normal-vs-Grade 3 |
8.452400E-01 |
| Normal-vs-Grade 4 |
9.556300E-02 |
| Grade 1-vs-Grade 2 |
6.738800E-01 |
| Grade 1-vs-Grade 3 |
5.779800E-01 |
| Grade 1-vs-Grade 4 |
6.506800E-01 |
| Grade 2-vs-Grade 3 |
9.809800E-01 |
| Grade 2-vs-Grade 4 |
5.985900E-02 |
| Grade 3-vs-Grade 4 |
5.976200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.098800E-01 |
| Normal-vs-ccB subtype |
1.333570E-01 |
| ccA subtype-vs-ccB subtype |
2.986800E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.573400E-01 |
| Normal-vs-N1 |
1.283420E-01 |
| N0-vs-N1 |
1.611820E-01 |
|
|
